Author(s):
Anisyah Achmad, Diah Permatasari, Thomas Erwin C. J. Huwae, Yoki Surya
Email(s):
3littleangels@ub.ac.id
DOI:
10.52711/0974-360X.2025.00050
Address:
Anisyah Achmad1*, Diah Permatasari1, Thomas Erwin C. J. Huwae2, Yoki Surya3
1Departement of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
2Departement of Orthopedics dan Traumatology, Faculty of Medicine, Universitas Brawijaya and Saiful Anwar Hospital, Malang, Indonesia.
3Department of Orthopedics and Traumatology, Brawijaya Army Hospital, Surabaya, Indonesia.
*Corresponding Author
Published In:
Volume - 18,
Issue - 1,
Year - 2025
ABSTRACT:
Osteoarthritis is a chronic degenerative disease of the joints that causes pain as its main symptoms. National and international guidelines recommend intra-articular corticosteroid injections as a non-surgical therapy option when the other therapeutic options are not optimal. The aim of the study was to determine the effective frequency after intra-articular injection of Triamcinolone Acetonide in knee joint pain in patients with osteoarthritis grade 2 - 3 Kellgren Lawrence. The study is a quantitative descriptive in oupatients at the Orthopaedic Police of Brawijaya Surabaya Hospital, Indonesia. This research is a quasi-experimental research using purposive sampling methods. Subjects were injected with intra-articular Triamcinolone acetonide at a dose of 20mg/2ml at different times by the clinician based on the results of X-rays of the knee joint. After that, the pharmacist followed the progress of the subject's knee joint pain using the Visual Analogue Scale (VAS) during control at the Orthopedic Polyclinic (every 2 weeks). Based on data on the first recurrence of pain, subjects were divided into 4 categories, namely frequency after injection 1 month, 2 months, 3 months and more than 3 months. During 1 year of research, the total subjects were 34 patients which consisted of women (82.4%), late elderly (41.2%), overweight (38.2%), and work outside the home (58.8%). Demographic factors such as gender, age, BMI, and work status did not correlate with VAS (p>0.05). The correlation of intra-articular Triamcinolone acetonide frequency with VAS is insignificant (p = 0.460; r = -0.131). There was an increase in the number of subjects with moderate to severe VAS after intra-articular corticosteroids after 3 months injection. The conclusion is that the analgesic effect of intra-articular injection of Triamcinolone acetonide is short-term, less than 3 months. Osteoarthritis pain will reappear 3 months after injection with moderate to severe symptom.
Cite this article:
Anisyah Achmad, Diah Permatasari, Thomas Erwin C. J. Huwae, Yoki Surya. Intra-articular Triamcinolone Acetonide Injection Effectiveness in Knee Joint pain patients with Osteoarthritis grade 2-3 Kellgren Lawrence. Research Journal of Pharmacy and Technology. 2025;18(1):321-5. doi: 10.52711/0974-360X.2025.00050
Cite(Electronic):
Anisyah Achmad, Diah Permatasari, Thomas Erwin C. J. Huwae, Yoki Surya. Intra-articular Triamcinolone Acetonide Injection Effectiveness in Knee Joint pain patients with Osteoarthritis grade 2-3 Kellgren Lawrence. Research Journal of Pharmacy and Technology. 2025;18(1):321-5. doi: 10.52711/0974-360X.2025.00050 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-1-50
REFERENCES:
1. Arvind J, Sarang J, Amit J. A Systematic Review of the Incidence, Prevalence Work Limitations of Osteoarthritis, Rheumatoid Arthritis, Back Pain, Multiple Sclerosis. Res. J. Pharmacology and Pharmacodynamics. 2020; 12(3): 103-110. https// doi: 10.5958/2321-5836.2020.00020.8
2. Royal Australian Collage of General Practicioners (RACGP). Guideline for the management of knee and hip osteoartritis. 2nd ed. East Melbourne, RACGP. 2018.
3. Minesh P, Pithadia AB, Prajapati B. Clinical Pharmacological Activity of Ayurvedic Treatments in an Osteoarthritis and it’s Benefits Outcomes: thnopharmacology Review. Asian Journal of Pharmacy and Technology. 2022; 12(4): 365-0. https://doi: 10.52711/2231-5713.2022.00057
4. Achmad A, Suharjono, Soeroso J, Nugroho CW, Surya Y. Association between Sodium Intake and Biopsychosocial Factors with Knee Joint Pain in Osteoarthritis patient. Research Journal of Pharmacy and Technology. 2023; 16(1): 323-7. https://doi: 10.52711/0974-360X.2023.00057
5. Indonesian Rheumatology Association (IRA). Recommendations for the Diagnosis and Management of Osteoarthritis. Jakarta. Indonesian Rheumatology Association. 2014.
6. Conaghan PG, Cook AD, Hamilton JA, Tak PP. Therapeutic options for targeting inflammatory osteoarthritis pain. In Nature Reviews Rheumatology. 2019; June; 15(6): 355–363. https://doi.org/10.1038/s41584-019-0221-y
7. Makhous R. Effectiveness and Safety of Glucosamine in the Treatment of Osteoarthritis. Research J. Pharm and Tech. 2018; 11(2): 489-493. https://doi: 10.5958/0974-360X.2018.00089.6
8. Buyuk AF, Kilinc E, Camurcu IY, Camur S, Ucpunar H, Kara A. Compared efficacy of intra-articular injection of methylprednisolone and triamcinolone. Acta Ortopedica Brasileira. 2017; Sept; 25(5): 206–208. https://doi.org/10.1590/1413-785220172505172581
9. The American Academy of Orthopaedic Surgeons (AAOS). Management of Osteoarthritis of the Knee (Non-Arthroplasty) Evidence-Based Clinical Practice Guideline. 2021. Available on https://www.aaos.org/oak3cpg
10. Kompel AJ, Roemer FW, Murakami AM, Diaz LE, Crema MD, Guermazi A. Intra-articular Corticosteroid Injections in the Hip and Knee: Perhaps not as safe as we thought? Radiology. 2019 Oct 15; 293(3): 656–663. https://doi.org/10.1148/radiol.2019190341
11. Buys LM, Wiedenfeld SA. Osteoarthritis in: Dipiro JT, Yee GC, Posey M, Haines ST, Nolin TD. Ellingrod, V. Pharmacotherapy : A Phatophysiologic Approach 11th Ed. USA. McGraw-Hill Education. 2020: p.106-108
12. Achmad A, Suharjono S, Soeroso J, Suprapti B, Siswandono S, Pristianty L, Rahmadi M, Nugraha J, Nugroho CW, Surya Y, Persada Isma SP, Rahadiansyah E, Huwae TECJ, Putra Suryana BP. The sodium does not affect joint pain and functional activity of knee osteoarthritis patients. Journal of Public Health in Africa. 2023b Oct 11;14(S1). https://doi.org/10.4081/jphia.2023.2494
13. Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. In World Journal of Orthopedics. 2014; Jul 18; 5(3): 351–361. https://doi.org/10.5312/wjo.v5.i3.351
14. Saltychev M, Mattie R, McCormick Z, Laimi K. The Magnitude and Duration of the Effect of Intra-articular Corticosteroid Injections on Pain Severity in Knee Osteoarthritis: A Systematic Review and Meta-Analysis. American Journal of Physical Medicine and Rehabilitation. 2020; Jul; 99(7): 617–625. https://doi.org/10.1097/PHM.0000000000001384
15. Testa G, Giardina SMC, Culmone A, Vescio A, Turchetta M, Cannavò S, Pavone V. Intra-articular injections in knee osteoarthritis: A review of literature. In Journal of Functional Morphology and Kinesiology. 2021; feb 3; 6(1).15 https://doi.org/10.3390/jfmk6010015
16. Paul J, Selvabharathi, C. Effect of Myofascial Release and Trigger Point Release among Osteoarthritis Knee Patients. Research J. Pharm and Tech. 2019; 12(11): 5351-5354. https://doi: 10.5958/0974-360X.2019.00929.6
17. Achmad A, Suharjono S, Soeroso J, Nugroho CW, Surya Y. Association between Sodium Intake and Biopsychosocial Factors with Knee Joint Pain in Osteoarthritis patient. Research J. Pharm. and Tech. 2023a; 16(1): 323-327. https://doi.org.10.52711/0974-360X.2023.00057
18. Aldosari AA, Majadah S, Amer KA, Alamri HH, Althomali RN, Alqahtani RF, Alamer RA, Alshehri SZ, Alhayyani R M, Aleman SY, Somaily M. The Association Between Physical Activity Level and Severity of Knee Osteoarthritis: A Single Centre Study in Saudi Arabia. Cureus. 2022. Available on: https://doi.org/10.7759/cureus.24377
19. Glass N, Segal NA, Sluka KA, Torner JC, Nevitt MC, Felson DT, Bradley LA, Neogi T, Lewis CE, Frey-Law LA. Examining sex differences in knee pain: The multicenter osteoarthritis study. Osteoarthritis and Cartilage. 2014; Aug; 22(8): 1100–1106. https://doi.org/10.1016/j.joca.2014.06.030
20. Sitinjak VM, Hastuti MF, Nurfiani A. The Effect of Rheumatic Exercise on Changes in Pain Scale in Elderly People with Knee Osteoarthritis. JKP. 2016; 4(2): 139 - 150. https://doi.org/10.24198/jkp.v4i2.234
21. Bharathi JK, Menaka P, Padmavathi. A Comparative study to assess the Effectiveness of selected Nursing Strategies Vs Acupressure and the Quality of Life on Osteoarthritis among Geriatric clients residing in selected old age homes in Tamilnadu –Pilot Study. Int. J. Adv. Nur. Management. 2016; 4(2): 107-110. https://doi: 10.5958/2454-2652.2016.00024.X
22. Raj NB, Saha S, Shokri AA, Saha S, Razali N, Othman NYH, Mahadeva Rao US. Effect of Isokinetic Training on Quadriceps Muscle Strength in Osteoarthritis of Knee. Research J. Pharm and Tech. 2018; 11(6): 2517-2524. https://doi: 10.5958/0974-360X.2018.00465.1
23. O’Neill TW, Felson DT. Mechanisms of Osteoarthritis (OA) Pain. In Current Osteoporosis Reports. 2018; Aug 28; 16(5): 611–616. https://doi.org/10.1007/s11914-018-0477-1
24. Shankland WE. Factors that affect pain behavior. Cranio - Journal of Craniomandibular and Sleep Practice. 2011; Feb 1; 29(2): 144–154. https://doi.org/10.1179/crn.2011.023
25. Juni P, Hari R, Rutjes AWS, Fischer R, Silletta MG, Reichenbach S, da Costa B.R. Intra-articular corticosteroid for knee osteoarthritis. Cochrane Database of Systematic Reviews, Issue 10. 2015. Art. No.: CD005328. Available on. https://doi.org/ 10.1002/14651858.CD005328.pub3.
26. Arumathy SCH, Haripriya, Prasanna Rao MV, Gayathri K, Sudhakar CHB, Divya M., Shanmugasundaram P. Clinical Comparison of the Efficacy and Safety of Intra-Articular Injections of Sodium Hyaluronate and MethylPrednisolone in the Treatment of Osteoarthritis of Knee. Research J. Pharm and Tech. 2015; Nov; 8(11): 1526-1528. https://doi: 10.5958/0974-360X.2015.00272.3
27. Martin C., Browne JA. Intra-articular Corticosteroid Injections for Symptomatic Knee Osteoarthritis: What the Orthopaedic Provider Needs to Know. Journal of the American Academy of Orthopaedic Surgeons. 2019; Sept 1; 27(17): E758–E766). https://doi.org/10.5435/JAAOS-D-18-00106
28. Kraus VB, Conaghan PG, Aazami HA, Mehra P, Kivitz AJ, Lufkin J, Hauben J, Johnson JR, Bodick N. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA). Osteoarthritis and Cartilage. 2018; Jan 26; 26(1): 34–42. https://doi.org/10.1016/j.joca.2017.10.003
29. Stout A, Friedly J, Standaert CJ. Systemic Absorption and Side Effects of Locally Injected Glucocorticoids. In PM and R. 2019 Des 18; 11(4):409–419. https://doi.org/10.1002/pmrj.12042
30. Derendorf H, Möllmann H, Grüner A, Haack D, Gyselby G. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra‐articular administration. Clinical Pharmacology and Therapeutics. 1986; Mar; 39(3); 313–317. https://doi.org/10.1038/clpt.1986.45
31. eo Yeong-Mi, Won Hee Choi, Tae Kyung Kim. Factors affecting The Pain of Osteoarthritis Patients. Research J. Pharm and Tech. 2019; 12(2): 699-705. https:// doi: 10.5958/0974-360X.2019.00124.0